Pushing and recognizing the limits of nonresponse to cardiac resynchronization therapy: A valuable "negative" trial.
Pushing and recognizing the limits of nonresponse to cardiac resynchronization therapy: A valuable "negative" trial. Heart Rhythm. 2018 06; 15(6):877-878.